Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (41-50 of 294) with videos related to

Pageof 30
Sort By:
British Journal of Haematology|November 1, 2006
Current management of follicular lymphomasWolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
Nature Immunology|February 19, 2013
The protease activity of the paracaspase MALT1 is controlled by monoubiquitinationChristiane Pelzer, Katrin Cabalzar, Annette Wolf, et al.
Deutsches Arzteblatt International|March 21, 2023
Diffuse Large B-Cell Lymphoma and Related EntitiesMoritz Ernst, Ulrich Dührsen, Dirk Hellwig, et al.
Anticancer Research|February 26, 2004
Metastasis of a rectal adenocarcinoma to the thyroid gland: diagnostic and therapeutic implicationsUlrich Hacker, Georg Lenz, Gerd Brehm, et al.
Deutsche Medizinische Wochenschrift (1946)|October 11, 2017
[Not Available]Georg Evers, Michael Mohr, Andrea Kerkhoff, et al.
Blood Advances|April 18, 2025
LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapiesYang Li, Corinna Kosnopfel, Daniela Schwammbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study GroupGeorg Lenz, Martin Dreyling, Eva Schiegnitz, et al.
Chemotherapy|August 15, 2008
Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinomaMaximilian Christopeit, Georg Lenz, Roswitha Forstpointner, et al.
Translational Lung Cancer Research|November 7, 2024
What do we know about the role of neoadjuvant targeted therapy in early-stage <i>EGFR</i>-mutant and <i>ALK</i>-fused non-small cell lung cancer?-a narrative review of the current literatureMarcel Kemper, Sandra Elges, Peter Kies, et al.
Cancers|February 11, 2023
Long-Term Survival of Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-Dose Chemotherapy and Stem Cell Transplantation: A Monocenter StudyKai Kröger, Jan Siats, Andrea Kerkhoff, et al.
Pageof 30

Showing results (41-50 of 294) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|November 1, 2006
Current management of follicular lymphomasWolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
Nature Immunology|February 19, 2013
The protease activity of the paracaspase MALT1 is controlled by monoubiquitinationChristiane Pelzer, Katrin Cabalzar, Annette Wolf, et al.
Deutsches Arzteblatt International|March 21, 2023
Diffuse Large B-Cell Lymphoma and Related EntitiesMoritz Ernst, Ulrich Dührsen, Dirk Hellwig, et al.
Anticancer Research|February 26, 2004
Metastasis of a rectal adenocarcinoma to the thyroid gland: diagnostic and therapeutic implicationsUlrich Hacker, Georg Lenz, Gerd Brehm, et al.
Deutsche Medizinische Wochenschrift (1946)|October 11, 2017
[Not Available]Georg Evers, Michael Mohr, Andrea Kerkhoff, et al.
Blood Advances|April 18, 2025
LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapiesYang Li, Corinna Kosnopfel, Daniela Schwammbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study GroupGeorg Lenz, Martin Dreyling, Eva Schiegnitz, et al.
Chemotherapy|August 15, 2008
Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinomaMaximilian Christopeit, Georg Lenz, Roswitha Forstpointner, et al.
Translational Lung Cancer Research|November 7, 2024
What do we know about the role of neoadjuvant targeted therapy in early-stage <i>EGFR</i>-mutant and <i>ALK</i>-fused non-small cell lung cancer?-a narrative review of the current literatureMarcel Kemper, Sandra Elges, Peter Kies, et al.
Cancers|February 11, 2023
Long-Term Survival of Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-Dose Chemotherapy and Stem Cell Transplantation: A Monocenter StudyKai Kröger, Jan Siats, Andrea Kerkhoff, et al.
Pageof 30